The project aims at providing scalable solution for bioproduction of therapy based on adeno associated virus (AAV).

AAVNova is a multidisciplinary project, which is carried out in collaboration with leading actors through different areas of competence. The project will deliver a platform with a series of tools such as viral vectors, cell lines, bioproduction process and new equipment as well as improved and simplified electron microscopy support with AI-based methods for the evaluation of the AAV quality.


Project Leader of Work Package 3: Veronique Chotteau

Active from CETEG: Ye Zhang (Post-doc), Emil Sundäng (Lab engineer)

Funding: VINNOVA and industrial partners